- Home
- RDHL vs KAVL Comparison
RDHL vs KAVL Comparison
Compare RDHL & KAVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RDHL | KAVL |
|---|---|---|
| Founded | 2009 | 1998 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8M | 9.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RDHL | KAVL |
|---|---|---|
| Price | $1.18 | $0.13 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 66.4K | ★ 5.2M |
| Earning Date | 09-05-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,550,000.00 | $1,127,037.00 |
| Revenue This Year | $381.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 157.62 | N/A |
| 52 Week Low | $1.01 | $0.12 |
| 52 Week High | $7.00 | $1.55 |
Technical Indicators
Market Signals| Indicator | RDHL | KAVL |
|---|---|---|
| Relative Strength Index (RSI) | 47.82 | 22.62 |
| Support Level | $1.15 | $0.14 |
| Resistance Level | $1.24 | $0.23 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 48.75 | 5.16 |
Price Performance
Historical ComparisonAbout RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About KAVL Kaival Brands Innovations Group Inc.
Kaival Brands Innovations Group Inc is focused on growing and incubating creative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.